Skip to main content

Table 1 Demographics, clinical features, and changes in ALSFRS-R

From: How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study

Mean age (years) ± SD 49.4 ± 11.8
Limb onset 31/43 (72.1%)
Bulbar onset 12/43 (27.9%)
Mean ALSFRS-R (Pre-Televisit) ± SD 31.7 ± 6.9
Mean ALSFRS-R (Televisit) ± SD 29.9 ± 6.5
  1. ALSFRS-R Revised Amyotrophic Lateral Sclerosis Functional Rating Scale